0001161697-24-000055.txt : 20240131
0001161697-24-000055.hdr.sgml : 20240131
20240131170128
ACCESSION NUMBER: 0001161697-24-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240130
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCENANY PATRICK J
CENTRAL INDEX KEY: 0000929985
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 24583799
MAIL ADDRESS:
STREET 1: C/O THERMOGENESIS CORP
STREET 2: 2711 CITRUS ROAD
CITY: RANCHO CORDOVA
STATE: CA
ZIP: 95742
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 01-30-2024
X0508
4
2024-01-30
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0000929985
MCENANY PATRICK J
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
1
0
0
1
Chairman of Board of Directors
0
Common Stock, par value $0.001 per share
2024-01-30
4
M
0
26333
A
4411589
D
Common Stock, par value $0.001 per share
2024-01-30
4
M
0
116667
A
4528256
D
Restricted Stock Units
2024-01-30
4
M
0
26333
0
D
Common Stock
26333
2709412
D
Restricted Stock Units
2024-01-30
4
M
0
116667
0
D
Common Stock
116667
2592745
D
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Pursuant to a Separation Agreement between the Company and the Reporting Person, the Reporting Person's restricted stock units that would have vested within the fifteen month period following January 1, 2024 immediately vested.
Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The shares were delivered on January 30, 2024.
/s/ Patrick J. McEnany
2024-01-31